Fortrea Holdings Inc. (FTRE)
Fortrea Holdings Inc. (FTRE) from its SEC filings: 2025 revenue $2.7 billion (+1% vs the year before), net margin -36%, free cash flow $113.5 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Services-Medical Laboratories |
| Revenue (2025) | $2.7 billion |
| Revenue growth | +1% |
| Net income | -$989.0 million |
| Net margin | -36.3% |
| Free cash flow | $113.5 million |
| Diluted EPS | $-10.81 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | -4% |
| Cash | $168.6 million |
| Long-term debt | $1.0 billion |
| Share count, 1 year | +5% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.